Mital Jhaveri: Anticoagulation in Advanced CKD – Why Individualized Decisions Matter
Mital Jhaveri, Clinical Anticoagulation, Heart Failure Pharmacist at NYC HHC Queens Hospital Center, shared a post on LinkedIn about a recent article by Kathrine Parker et al., published in BMC Nephrology Journals, adding:
“Anticoagulation in advanced kidney disease: when both clotting and bleeding risk are high, what is the right choice?
A newly published 2026 guideline highlights a challenge we face frequently in practice: patients with advanced CKD have increased risks of stroke, systemic embolism, and bleeding – yet they have historically been excluded from many major anticoagulation trials.
One particularly striking point: major DOAC trials largely excluded patients with CrCl less than 30 mL/min, leaving us with limited high-quality evidence precisely where thrombotic and bleeding risks are both high.
As a pharmacist working in anticoagulation, this reinforces that anticoagulation is never simply about choosing a drug and dose.
Renal function, bleeding risk, stroke risk, monitoring, and the individual patient all matter.
The best anticoagulation decision is an individualized one.”
Title: Anticoagulation for atrial fibrillation in adults with advanced kidney disease: UK kidney association clinical practice guideline
Authors: Kathrine Parker, Albert Power, Richard Buka, Mark Davies, Maria A. Gauci, Alan Hancock, John Hartemink, Anneka Mitchell, Honey Thomas, Jung Yin Tsang, Isaac Tseng, Andrew Turley, Gregory Y. H.
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 27, 2026, 14:40Santagata Davide: Thrombin Generation and Comparative Anticoagulant Pharmacodynamics
-
Aug 27, 2026, 14:33Shaleen Dass: Early Prediction of Blood Transfusion Requirements in Trauma Patients
-
Aug 27, 2026, 14:26Davide Capodanno: The Trade-Offs of Left Atrial Appendage Closure
-
Aug 27, 2026, 14:18A Simple Intervention to Reduce Maternal Anemia – UT Southwestern Medical Center
-
Aug 27, 2026, 14:02Jonathan Douxfils: Can Untreated Heavy Menstrual Bleeding Increase the Risk of Venous Thromboembolism?
-
Aug 27, 2026, 13:55Steven Fein: Evaluating Patients With Bleeding Disorders
-
Aug 27, 2026, 13:52Terry Nguyen: VWD as the Most Common Bleeding Disorder
-
Aug 27, 2026, 13:49Sweta Kothari: Clinical Assessment of Thrombocytopenia Beyond Platelet Count
-
Aug 27, 2026, 13:43Claudio Laudani: Left Atrial Appendage Closure vs Anticoagulation in AF